Hamid Mukhtar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hamid Mukhtar has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Kálmán Imre
Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timişoara, 300645 Timișoara, Romania
1 shared publication - Muhammad Tahir Hayat
Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University
1 shared publication - Muhammad Uzair Javed
Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan
1 shared publication
Latest Publications
- Open Access
- 19 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1075
CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Antibiotic resistance is rising to dangerously high levels throughout the world. To cope with this problem, scientists are working on CRISPR-based research so that antibiotic-resistant bacteria can be killed and attacked almost as quickly as antibiotic-sensitive bacteria. Nuclease activity is found in Cas9, which can be programmed with a specific target sequence. This mechanism will only attack pathogens in the microbiota while preserving commensal bacteria. This article portrays the delivery methods used in the CRISPR-Cas system, which are both viral and non-viral, along with its implications and challenges, such as microbial dysbiosis, off-target effects, and failure to counteract intracellular infections. CRISPR-based systems have a lot of applications, such as correcting mutations, developing diagnostics for infectious diseases, improving crops productions, improving breeding techniques, etc. In the future, CRISPR-based systems will revolutionize the world by curing diseases, improving agriculture, and repairing genetic disorders. Though all the drawbacks of the technology, CRISPR carries great potential; thus, the modification and consideration of some aspects could result in a mind-blowing technique to attain all the applications listed and present a game-changing potential.
- 19 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1075
Open AccessCRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Antibiotic resistance is rising to dangerously high levels throughout the world. To cope with this problem, scientists are working on CRISPR-based research so that antibiotic-resistant bacteria can be killed and attacked almost as quickly as antibiotic-sensitive bacteria. Nuclease activity is found in Cas9, which can be programmed with a specific target sequence. This mechanism will only attack pathogens in the microbiota while preserving commensal bacteria. This article portrays the delivery methods used in the CRISPR-Cas system, which are both viral and non-viral, along with its implications and challenges, such as microbial dysbiosis, off-target effects, and failure to counteract intracellular infections. CRISPR-based systems have a lot of applications, such as correcting mutations, developing diagnostics for infectious diseases, improving crops productions, improving breeding techniques, etc. In the future, CRISPR-based systems will revolutionize the world by curing diseases, improving agriculture, and repairing genetic disorders. Though all the drawbacks of the technology, CRISPR carries great potential; thus, the modification and consideration of some aspects could result in a mind-blowing technique to attain all the applications listed and present a game-changing potential.